Biotechne sec filings
WebTab l e of C on t e n t s Tab l e of C on t e n t s P age PA RT I I t e m 1. B us i ne s s 1 I t e m 1A . R i s k F a c t or s 51 I t e m 1B . WebApr 14, 2024 · The stock has a market cap of $13.14 billion, a price-to-earnings ratio of 51.89, a PEG ratio of 2.39 and a beta of 1.25. The company has a quick ratio of 3.15, …
Biotechne sec filings
Did you know?
WebApr 12, 2024 · SEC filings and transcripts for Bio-Techne Corp, including financials, news, proxies, indentures, prospectuses, ... Letter from the SEC 02/16/23 CORRESP … WebApr 13, 2024 · Fifth Third Bancorp grew its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Get Rating) by 575.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission.The institutional investor owned 2,325 shares of the biotechnology company's stock after …
WebApr 10, 2024 · Berger Financial Group Inc raised its stake in Bio-Techne Co. (NASDAQ:TECH - Get Rating) by 300.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).The institutional investor owned 43,740 shares of the biotechnology company's stock after acquiring an additional … WebApr 13, 2024 · Fifth Third Bancorp grew its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Get Rating) by 575.9% during the fourth quarter, according to the …
WebApr 14, 2024 · National Bank of Canada FI raised its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Get Rating) by 3,001.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission.The fund owned 4,621 shares of the biotechnology company's stock after purchasing an additional 4,472 shares during … WebApr 14, 2024 · Shares of TECH opened at $83.55 on Friday. The firm has a 50-day moving average of $74.91 and a 200-day moving average of $79.72. Bio-Techne Co. has a one year low of $68.00 and a one year high of ...
WebJul 21, 2024 · Search SEC.gov. Company Filings. U.S. Securities and Exchange Commission
Web11 rows · Apr 4, 2024 · SC 13G/A. Schedule filed to report acquisition of beneficial … diamond art subscriptionWebPublish Your Results With R&D Systems ELISA Kits. Whether you are profiling the immune system, on the cutting edge of drug discovery, or evaluating a therapeutic response during a clinical trial Bio-Techne has an ELISA format to fit your needs. Quantikine - Ready-to-use, ready-to-publish sandwich ELISAs. QuicKits - Get your results faster. circle line beast speedboat rideWebEvents. Date. Location. Details. American Association for Cancer Research (AACR) Visit Website. April 14 – April 19, 2024: Orlando, FL: Booth #1763. Posters circle line art school roseWebApr 11, 2024 · The firm owned 232,146 shares of the biotechnology company's stock after buying an additional 191,238 shares during the period. Natixis Advisors L.P. owned approximately 0.15% of Bio-Techne worth $19,240,000 as of its most recent filing with the Securities and Exchange Commission. Bio-Techne, J2 Global And InMode Break Out … circle line best of new york cruiseWebApr 12, 2024 · Daiwa Securities Group Inc. now owns 3,384 shares of the biotechnology company’s stock valued at $961,000 after buying an additional 38 shares during the period. diamond art sunflowerWebBio-Techne Corp. SEC filings breakout by MarketWatch. View the TECH U.S. Securities and Exchange Commission reporting information. diamond art suncatchersWebFeb 7, 2024 · SEC Filings; Overview; News / Events. Overview; Press Releases; IR Calendar; Email Alerts; Company Info. Overview; Profile; Presentations; Management Team; Contacts; FAQ; Financial Info. Overview; Balance Sheet; Income Statement; … 614 McKinley Place NE Minneapolis, MN 55413 USA TEL 612 379 2956 Toll-free … 614 McKinley Place NE Minneapolis, MN 55413 USA TEL 612 379 2956 Toll-free … diamond art stylus